Skip to main content
    A

    Aprea Therapeutics Inc (APRE)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $0.41
    -0.01 (-2.38%)

    Market Cap: $5.91M

    Last updated: Nov 17, 2026 at 11:02 AM ET

    Aprea Therapeutics Inc (APRE) Earnings: Report Dates and Results

    Updated Nov 4, 2026. Results come from company earnings reports, and estimates are consensus analyst estimates.

    Aprea Therapeutics (APRE) is expected to report earnings on Mar 15, 2027. In the quarter ended Sep 30, 2026, Aprea Therapeutics reported EPS of -$0.09, below the -$0.08 estimate. It beat the EPS estimate in 6 of the last 8 quarters.

    Earnings

    Performance (10Y)

    Beat Rate
    62%(18/29)
    Avg Surprise
    -5.35%

    Upcoming Estimates

    Reports Mar 15, 2027 (est.)Period ending Dec 31, 2026
    EPS Consensus-$0.09
    Range-$0.11 - -$0.05
    6 analysts
    Revenue Consensus
    N/A
    RangeN/A
    4 analysts
    Reports May 11, 2027 (est.)Period ending Mar 31, 2027
    EPS Consensus-$0.13
    Range-$0.13 - -$0.13
    1 analysts
    EPS RevisionsNo revisions (30d)
    EPS Estimate DriftChange to current
    90d ago-$0.25+48.0%
    60d ago-$0.08-62.5%
    30d ago-$0.08-62.5%
    7d ago-$0.11-23.8%
    Current-$0.13
    Revenue Consensus
    N/A
    RangeN/A
    2 analysts

    Next Report

    APRE has an expected report date of Mar 15, 2027.

    Earnings History

    Of the 29 quarters below that had an estimate, APRE beat 18 and missed 11. The widest gap in the table came in the quarter ended Jun 30, 2022, when EPS landed 216.61% below the estimate.

    Quarter endedEPSEstimateRangeSurpriseResultYoYAnalystsRevisionsReportedRevenue
    Sep 30, 2026-$0.09-$0.08-$0.09 - -$0.07-12.50%MissN/A30 up, 0 downNov 4, 2026N/A
    Jun 30, 2026-$0.07-$0.22-$0.23 - -$0.21+68.18%BeatN/A20 up, 0 downAug 12, 2026N/A
    Mar 31, 2026-$0.22-$0.23-$0.23 - -$0.23+4.35%BeatN/A10 up, 0 downMay 13, 2026N/A
    Dec 31, 2025-$0.32-$0.36-$0.37 - -$0.35+11.11%BeatN/A20 up, 0 downMar 16, 2026$3337
    Sep 30, 2025-$0.47-$0.34N/A-38.24%MissN/A10 up, 0 downNov 12, 2025$1848
    Jun 30, 2025-$0.53-$0.71-$0.71 - -$0.71+25.35%BeatN/A10 up, 0 downAug 12, 2025$118111
    Mar 31, 2025-$0.66-$1.00N/A+34.39%BeatN/A21 up, 0 downMay 14, 2025$162463
    Dec 31, 2024-$0.49-$0.54-$0.54 - -$0.54+9.26%BeatN/A11 up, 0 downMar 25, 2025$205817
    Sep 30, 2024-$0.64-$0.74-$0.87 - -$0.62+13.51%BeatN/A20 up, 0 downNov 7, 2024$354621
    Jun 30, 2024-$0.58-$0.60-$0.69 - -$0.58+3.33%BeatN/A20 up, 0 downAug 12, 2024$561574
    Mar 31, 2024-$0.67-$0.80-$0.80 - -$0.75+16.25%BeatN/A20 up, 0 downMay 14, 2024$380569
    Dec 31, 2023-$0.92-$0.77-$1.20 - -$0.19-19.48%MissN/A30 up, 0 downMar 26, 2024$14075
    Sep 30, 2023-$0.86-$1.04-$1.33 - -$1.04+17.31%BeatN/A30 up, 0 downNov 9, 2023$319468
    Jun 30, 2023-$0.87-$1.38-$1.47 - -$1.38+36.96%BeatN/A20 up, 0 downAug 10, 2023$249688
    Mar 31, 2023-$1.34-$0.82-$2.19 - -$0.82-63.41%MissN/A20 up, 0 downMay 15, 2023N/A
    Dec 31, 2022-$0.92-$3.08-$4.04 - -$2.40+70.13%BeatN/A30 up, 0 downMar 30, 2023N/A
    Sep 30, 2022-$2.40-$1.60N/A-50.00%MissN/A20 up, 0 downNov 9, 2022N/A
    Jun 30, 2022-$19.63-$6.20N/A-216.61%MissN/A20 up, 0 downAug 11, 2022N/A
    Mar 31, 2022-$7.20-$7.60-$7.60 - -$7.60+5.26%BeatN/A10 up, 0 downMay 16, 2022N/A
    Dec 31, 2021-$7.20-$8.80-$8.80 - -$8.80+18.18%BeatN/A30 up, 0 downMar 15, 2022N/A
    Sep 30, 2021-$9.00-$9.05-$9.80 - -$8.00+0.55%BeatN/A42 up, 0 downNov 8, 2021N/A
    Jun 30, 2021-$9.60-$9.35-$10.20 - -$8.20-2.67%MissN/A4N/AAug 12, 2021N/A
    Mar 31, 2021-$9.20-$9.85-$12.40 - -$8.00+6.60%BeatN/A4N/AMay 6, 2021N/A
    Dec 31, 2020-$14.60-$12.85-$13.80 - -$10.60-13.62%MissN/A4N/AMar 16, 2021N/A
    Sep 30, 2020-$11.60-$15.20-$16.60 - -$14.00+23.68%BeatN/A5N/ANov 5, 2020N/A
    Jun 30, 2020-$15.60-$12.05-$13.00 - -$11.60-29.46%MissN/A4N/AAug 11, 2020N/A
    Mar 31, 2020-$9.00-$11.35-$12.80 - -$9.60+20.70%BeatN/A4N/AMay 15, 2020N/A
    Dec 31, 2019-$12.80-$8.00-$8.40 - -$7.60-60.00%MissN/A3N/AMar 26, 2020N/A
    Sep 30, 2019-$105.80-$78.87-$117.60 - -$12.60-34.14%MissN/A3N/AOct 3, 2019N/A
    Jun 30, 2019-$0.31N/AN/AN/AN/AN/AN/AN/AAug 28, 2019N/A
    Last 30 quarters

    Annual EPS

    EPS for the fiscal year ended Dec 31, 2025 was -$1.98, after -$2.38 the year before. It was -$118.91 for the year ended Dec 31, 2019, the oldest of the 7 fiscal years shown.

    Fiscal year endedEPSChange
    Dec 31, 2025-$1.98N/A
    Dec 31, 2024-$2.38N/A
    Dec 31, 2023-$3.99N/A
    Dec 31, 2022-$30.15N/A
    Dec 31, 2021-$35.00N/A
    Dec 31, 2020-$50.80N/A
    Dec 31, 2019-$118.91N/A

    Frequently Asked Questions About APRE

    When is Aprea Therapeutics's next earnings date?

    Aprea Therapeutics's next earnings report is expected for Mar 15, 2027.

    Did APRE beat earnings estimates last quarter?

    No. Aprea Therapeutics reported EPS of -$0.09 for the quarter ended Sep 30, 2026, below the -$0.08 estimate by 12.50%.

    What EPS do analysts expect from APRE next quarter?

    The consensus EPS estimate for Aprea Therapeutics for the quarter ending Dec 31, 2026 is -$0.09 from 6 analysts, with estimates from -$0.11 to -$0.05.

    How often does APRE beat earnings estimates?

    Aprea Therapeutics beat the EPS estimate in 6 of the last 8 quarters, with an average surprise of +12.74%.